Medscape reports strong weight loss results for teens on GLP-1 medications, while noting there's still little data on long-term effects or growth.
Recap by typeshit. Full story at Medscape.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Robert Lufkin MD shares the observational data: an average 16.1 kg lost at six months among 7,297 women, with 62.7% reporting side effects.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Retatrutide is still in clinical trials, but PharmaVoice reports Lilly is already going after a network of illicit sellers offering it online.
Lilly says it has flagged over 14,000 listings and referred 200+ sellers to regulators. One analyst says illicit buyers pay about $200 a month.
Loading…